Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 3501-3510 of 10954

Edit search filters
  1. A Study Comparing Scrambler Therapy versus TENS Therapy in Treating Patients with Chemotherapy-Induced Peripheral Neuropathy

    Rochester, MN

  2. A Study Comparing Sodium Nitroprusside and Nitroglycerin to Determine the Dose of Each Needed to get the Same Response

    Rochester, MN

  3. A Study to Assess Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia

    Rochester, MN

  4. A Study of the Effect of Relamorelin on Satiation, and on Gastric Volume, Accommodation and Function in Healthy Volunteers

    Rochester, MN

  5. Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer

    Rochester, MN

  6. A Study of the Combination of IMCgp100 with Durvalumab and/or Tremelimumab for Patients with Advanced Cutaneous Melanoma

  7. Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease

    Rochester, MN

  8. A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia

    Rochester, MN

  9. A Study to Compare Conventional Heart Echo Measurements with Newer 2 and 3 Dimensional Measurements of Mechanical Heart Strain after Trastuzumab Infusion

    Rochester, MN

  10. Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services

    La Crosse, WI

.

Mayo Clinic Footer